• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care
Prostate Cancer : Episode 11

Episode 11 - Personalized Medicine in CRPC

Video

During this segment, the panelists explore the use of personalized medicine in castration-resistant prostate cancer.

Jeffrey D. Dunn, PharmD, MBA, and Raoul S. Concepcion, MD, explain that clinicians hope to have better data available in the future to provide definitive answers about treatment options for specific patient populations.

Dr Concepcion explains the variables that are being reviewed to help clinicians make wiser treatment decisions for their patients.

However, E. David Crawford, MD, reminds the panelists why achieving this goal will not be easy.


Related Videos
Jaime Almandoz, MD, MBA
Martin Edelman, MD
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
Pierluigi Porcu, MD
Image credit: Medical technology and futuristic concept. Doctor hologram modern virtual screen interface | SOMKID - stock.adobe.com
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Elizabeth Grush, MBA
Cathy Eng, MD, FACP, FASCO, Vanderbilt-Ingram Cancer Center
Erin Weber, MS
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.